Mountain View, California
United States
105
2026-01-15
The entities that hold a legal rights for patent applications filed by inventor Buggy Joseph J.:
Joseph J. Buggy from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:
USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#2 | 2025-04-24USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#3 | 2024-09-26INHIBITORS OF BRUTON'S TYROSINE KINASE
#4 | 2024-02-29METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE
#5 | 2023-09-21USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#6 | 2023-08-10USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#7 | 2022-08-11USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#8 | 2022-07-07Inhibitors of Bruton's Tyrosine Kinase
#9 | 2022-06-09USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#10 | 2021-11-25USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#11 | 2021-06-10Use of inhibitors of Brutons tyrosine kinase (Btk)
#12 | 2021-05-20METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER
#13 | 2020-09-17INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
#14 | 2020-09-03INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
#15 | 2020-08-06METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE
#16 | 2020-05-28Use of inhibitors of Bruton's tyrosine kinase (Btk)
#17 | 2020-05-14TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
#18 | 2020-02-20INHIBITORS OF BRUTONS TYROSINE KINASE
#19 | 2019-11-28Use of inhibitors of bruton's tyrosine kinase (BTK)
#20 | 2019-06-20FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#21 | 2019-06-06METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER
#22 | 2018-11-01METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE
#23 | 2018-10-04USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#24 | 2018-09-13Use of inhibitors of bruton's tyrosine kinase (Btk)
#25 | 2018-07-12INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
#26 | 2018-03-15Methods for the treatment of HER2 amplified cancer
#27 | 2018-03-15TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
#28 | 2018-02-08Use of inhibitors of Bruton's tyrosine kinase (Btk)
#29 | 2018-01-18Use of inhibitors of Bruton's tyrosine kinase (Btk)
#30 | 2017-12-21INHIBITORS OF BRUTON'S TYROSINE KINASE
#31 | 2017-11-23Formulations of histone deacetylase inhibitor and uses thereof
#32 | 2017-09-21USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#33 | 2017-08-31Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
#34 | 2017-06-01Methods for the treatment of HER2 amplified cancer
#35 | 2017-02-09Use of inhibitors of Bruton'S tyrosine kinase (Btk)
#36 | 2016-11-10Use of inhibitors of bruton's tyrosine kinase (BTK)
#37 | 2016-08-25METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE
#38 | 2016-06-23Use of inhibitors of bruton's tyrosine kinase (Btk)
#39 | 2016-06-09METHODS FOR DETERMINING CANCER RESISTANCE TO HISTONE DEACETYLASE INHIBITORS
#40 | 2016-01-07Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
#41 | 2015-11-12SELECTIVE INHIBITORS OF HISTONE DEACTYLASE
#42 | 2015-11-12Hydroxamates as therapeutic agents
#43 | 2015-10-29INHIBITORS OF BRUTON'S TYROSINE KINASE
#44 | 2015-10-29Inhibitors of Bruton's tyrosine kinase
#45 | 2015-10-22Indole derivatives as inhibitors of histone deacetylase
#46 | 2015-09-24INHIBITORS OF BRUTON'S TYROSINE KINASE
#47 | 2015-07-02Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
#48 | 2015-06-18FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF
#49 | 2015-06-04INHIBITORS OF BRUTON'S TYROSINE KINASE
#50 | 2015-05-14Inhibitors of bruton's tyrosine kinase
#51 | 2015-02-12Methods for the treatment of HER2 amplified cancer
#52 | 2015-02-05USES OF SELECTIVE INHIBITORS OF HDAC8 AND TREATMENT OF INFLAMMATORY CONDITIONS
#53 | 2015-01-29Use of inhibitors of Bruton's tyrosine kinase (Btk)
#54 | 2015-01-29USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#55 | 2014-12-18TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
#56 | 2014-11-20Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
#57 | 2014-10-09USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#58 | 2014-10-09NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
#59 | 2014-07-10Use of inhibitors of bruton's tyrosine kinase (BTK)
#60 | 2014-05-15TEC family kinase inhibitor adjuvant therapy
#61 | 2014-03-20Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumors
#62 | 2014-02-27INHIBITORS OF BRUTON'S TYROSINE KINASE
#63 | 2014-02-27Formulations of histone deacetylase inhibitor and uses therof
#64 | 2014-01-02Selective inhibitors of histone deacetylase
#65 | 2013-11-21USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#66 | 2013-10-17USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#67 | 2013-08-08USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#68 | 2013-08-01Use of inhibitors of Bruton's tyrosine kinase (Btk)
#69 | 2013-07-11Methods and Compositions for Inhibition of Bone Resorption
#70 | 2013-06-20Indole derivatives as inhibitors of histone deacetylase
#71 | 2013-06-06Hydroxamates as therapeutic agents
#72 | 2013-03-28USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS
#73 | 2013-02-07Inhibitors of bruton's tyrosine kinase
#74 | 2013-01-17INHIBITORS OF BRUTON'S TYROSINE KINASE
#75 | 2012-12-27INHIBITORS OF BRUTON'S TYROSINE KINASE
#76 | 2012-11-22INHIBITORS OF BRUTON'S TYROSINE KINASE
#77 | 2012-11-01Inhibitors of bruton's tyrosine kinase
#78 | 2012-11-01Inhibitors of Bruton'S tyrosine kinase
#79 | 2012-08-09INHIBITORS OF IL2-INDUCIBLE T-CELL KINASE
#80 | 2012-07-19INHIBITORS OF BRUTON'S TYROSINE KINASE
#81 | 2012-07-19Inhibitors of BMX non-receptor tyrosine kinase
#82 | 2012-07-19Use of inhibitors of bruton's tyrosine kinase (Btk)
#83 | 2012-07-12Inhibitors of Bruton's tyrosine kinase
#84 | 2012-06-28INHIBITORS OF B LYMPHOCYTE KINASE
#85 | 2012-04-26INHIBITORS OF BRUTON'S TYROSINE KINASE
#86 | 2012-04-26INHIBITORS OF BRUTON'S TYROSINE KINASE
#87 | 2012-04-26THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#88 | 2012-04-12USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#89 | 2012-03-22METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE
#90 | 2012-03-15INHIBITORS OF BRUTON'S TYROSINE KINASE
#91 | 2012-03-15Hydroxamates as therapeutic agents
#92 | 2011-12-22Formulations of histone deacetylase inhibitor and uses thereof
#93 | 2011-06-23USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS
#94 | 2011-04-07Selective inhibitors of histone deacetylase
#95 | 2011-03-03Methods for determining cancer resistance to histone deacetylase inhibitors
#96 | 2011-01-27Hydroxamates as therapeutic agents
#97 | 2010-11-11CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE
#98 | 2010-10-07Inhibitors of Bruton's tyrosine kinase
#99 | 2009-10-29Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
#100 | 2009-09-03Hydroxamates as therapeutic agents
42527 ⎘